glutamine has been researched along with Cardiomyopathy, Hypertrophic in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 6 (40.00) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boussaada, R; Finsterer, J; Mehri, S; Ouarda, F; Zarrouk-Mahjoub, S | 1 |
| Aguiar-Pulido, V; Huang, W; Kazmierczak, K; Narasimhan, G; Szczesna-Cordary, D; Zhou, Z | 1 |
| Csanády, M; Faludi, R; Forster, T; Nagy, V; Nemes, A; Sepp, R; Simor, T; Tóth, T | 1 |
| Nallari, P; Narasimhan, C; Priyamvada, S; Rani, DS; Singh, L; Thangaraj, K | 1 |
| Alpert, NR; Fishbaugher, DE; Maughan, DW; Palmer, BM; Schmitt, JP; Seidman, CE; Seidman, JG; VanBuren, P; Wang, Y | 1 |
| Chen, S; Kopelen, HA; Lutucuta, S; Marian, AJ; Nagueh, SF; Patel, R; Quiñones, MA; Roberts, R; Tsybouleva, N; Zoghbi, WA | 1 |
| Beuger, S; Boer, K; Godfried, MH; Kuijpers, TW; Scherpbier, HJ | 1 |
| Hamada, M; Hara, Y; Higaki, J; Kohara, K; Miki, T; Nakura, J; Ogimoto, A; Ohtsuka, T; Shigematsu, Y | 1 |
| Kogaki, S; Kurotobi, S; Nasuno, S; Ohta, M; Okabe, H; Ozono, K; Sakai, N; Takahashi, K; Taniike, M; Wada, K | 1 |
| Baylen, BG; Consevage, MW; Ladda, RL; Rogan, PK; Salada, GC | 1 |
| Eldin, P; Le Cunff, M; Leger, JJ; Mornet, D | 1 |
| Faust, L; Leinwand, LA; Straceski, AJ; Sweeney, HL; Tikunov, BA | 1 |
| Cohn, G; Cyran, F; Dalakas, MC; Epstein, ND; Fananapazir, L | 1 |
| Aronovitz, MJ; Berul, CI; Christe, ME; Maguire, CT; Mendelsohn, ME; Seidman, CE; Seidman, JG | 1 |
| Faro, C; Gonçalves, LM; Pires, E; Providência, LA; Ventura, M; Vieira, M | 1 |
15 other study(ies) available for glutamine and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
Mitochondrial tRNA glutamine variant in hypertrophic cardiomyopathy.
Topics: Adolescent; Base Sequence; Cardiomyopathy, Hypertrophic; DNA, Mitochondrial; Genetic Markers; Genetic Predisposition to Disease; Genetic Variation; Glutamine; Humans; Male; Molecular Sequence Data; Polymorphism, Single Nucleotide; RNA, Transfer | 2015 |
Gene expression patterns in transgenic mouse models of hypertrophic cardiomyopathy caused by mutations in myosin regulatory light chain.
Topics: Algorithms; Animals; Arginine; Cardiomyopathy, Hypertrophic; Computational Biology; Gene Expression Profiling; Gene Expression Regulation; Glutamic Acid; Glutamine; Lysine; Mice; Mice, Transgenic; Multigene Family; Mutation; Myocardium; Myosin Light Chains; Oligonucleotide Array Sequence Analysis; Phenotype; Principal Component Analysis; Valine | 2016 |
The Gln1233ter mutation of the myosin binding protein C gene: causative mutation or innocent polymorphism in patients with hypertrophic cardiomyopathy?
Topics: Adolescent; Adult; Cardiomyopathy, Hypertrophic; Carrier Proteins; Female; Glutamine; Humans; Male; Middle Aged; Mutation; Pedigree; Polymorphism, Genetic; Young Adult | 2011 |
High prevalence of Arginine to Glutamine substitution at 98, 141 and 162 positions in Troponin I (TNNI3) associated with hypertrophic cardiomyopathy among Indians.
Topics: Adult; Alleles; Arginine; Asian People; Binding Sites; Cardiomyopathy, Hypertrophic; Case-Control Studies; Death, Sudden, Cardiac; Exons; Female; Glutamine; Heterozygote; Humans; India; Introns; Male; Middle Aged; Pedigree; Polymorphism, Single Nucleotide; Prevalence; Troponin I | 2012 |
Differential cross-bridge kinetics of FHC myosin mutations R403Q and R453C in heterozygous mouse myocardium.
Topics: Actins; Adenosine Triphosphatases; Animals; Arginine; Calcium; Cardiomyopathy, Hypertrophic; Cysteine; Enzyme Activation; Glutamine; Heterozygote; In Vitro Techniques; Isometric Contraction; Kinetics; Male; Mice; Mutation, Missense; Myocardial Contraction; Myocardium; Myosin Heavy Chains; Point Mutation; Time Factors; Ventricular Myosins | 2004 |
Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.
Topics: Adenosine Triphosphatases; Aging; Animals; Animals, Genetically Modified; Calcium; Cardiomyopathy, Hypertrophic; Disease Models, Animal; Echocardiography; Glutamine; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myocardial Contraction; Myofibrils; Myosin Heavy Chains; Nonmuscle Myosin Type IIB; Phenotype; Rabbits; Signal Transduction; Time Factors; Transgenes | 2004 |
A neonate with macrosomia, cardiomyopathy and hepatomegaly born to an HIV-infected mother.
Topics: Adipose Tissue; Antiretroviral Therapy, Highly Active; Arginine; Asphyxia; Brain; Cardiomegaly; Cardiomyopathy, Hypertrophic; Cholestasis; Fatal Outcome; Female; Fetal Macrosomia; Glutamine; Hepatomegaly; HIV Infections; Humans; Hypoglycemia; Infant, Newborn; Infectious Disease Transmission, Vertical; Lactic Acid; Liver Function Tests; Myocardium; Necrosis; Pregnancy; Pregnancy Complications, Infectious; Skin Diseases | 2005 |
Endothelial nitric oxide synthase gene polymorphism (Glu298Asp) in patients with coexistent hypertrophic cardiomyopathy and coronary spastic angina.
Topics: Amino Acid Substitution; Angina Pectoris; Aspartic Acid; Cardiomyopathy, Hypertrophic; Female; Glutamine; Humans; Japan; Male; Middle Aged; Nitric Oxide Synthase Type III; Polymorphism, Genetic; Risk Factors | 2005 |
A novel mutation in the PTPN11 gene in a patient with Noonan syndrome and rapidly progressive hypertrophic cardiomyopathy.
Topics: Cardiomyopathy, Hypertrophic; Cardiovascular Agents; Chromosomes, Human, Pair 12; Drug Therapy, Combination; Glutamic Acid; Glutamine; Humans; Imidazoles; Infant; Intracellular Signaling Peptides and Proteins; Male; Mutation, Missense; Noonan Syndrome; Propranolol; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatases; Treatment Outcome | 2005 |
A new missense mutation, Arg719Gln, in the beta-cardiac heavy chain myosin gene of patients with familial hypertrophic cardiomyopathy.
Topics: Amino Acid Sequence; Arginine; Base Sequence; Cardiomyopathy, Hypertrophic; Chromosome Mapping; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 14; Chromosomes, Human, Pair 15; DNA; DNA Primers; Female; Glutamine; Humans; Male; Molecular Sequence Data; Myocardium; Myosins; Pedigree; Point Mutation; Polymerase Chain Reaction; Reference Values | 1994 |
The cardiac myosin heavy chain Arg-403-->Gln mutation that causes hypertrophic cardiomyopathy does not affect the actin- or ATP-binding capacities of two size-limited recombinant myosin heavy chain fragments.
Topics: Actins; Adenosine Triphosphate; Arginine; Base Sequence; Binding Sites; Cardiomyopathy, Hypertrophic; Gene Expression; Glutamine; Heart Ventricles; Humans; Molecular Sequence Data; Mutation; Myocardium; Myosins; Peptide Fragments; Polymerase Chain Reaction; Recombinant Proteins; RNA, Messenger; Structure-Activity Relationship | 1995 |
Heterologous expression of a cardiomyopathic myosin that is defective in its actin interaction.
Topics: Actins; Adenosine Triphosphatases; Amino Acid Sequence; Animals; Arginine; Binding Sites; Calcium-Transporting ATPases; Cardiomyopathy, Hypertrophic; Cation Transport Proteins; Cell Line; Gene Expression; Glutamine; Humans; Myocardium; Myosins; Point Mutation; Protein Binding; Rats; Transfection | 1994 |
Missense mutations in the beta-myosin heavy-chain gene cause central core disease in hypertrophic cardiomyopathy.
Topics: Adolescent; Adult; Amino Acid Sequence; Arginine; Base Sequence; Cardiomyopathy, Hypertrophic; Child, Preschool; Codon; DNA; Exons; Female; Glutamine; Humans; Introns; Leucine; Leukocytes; Male; Microscopy, Electron; Middle Aged; Molecular Sequence Data; Muscles; Myosins; Oligodeoxyribonucleotides; Pedigree; Point Mutation; Polymerase Chain Reaction; Polymorphism, Genetic; Valine | 1993 |
Familial hypertrophic cardiomyopathy mice display gender differences in electrophysiological abnormalities.
Topics: Animals; Arginine; Cardiac Pacing, Artificial; Cardiomyopathy, Hypertrophic; Case-Control Studies; Electrocardiography; Female; Glutamine; Heart Conduction System; Heart Rate; Heart Ventricles; Heterozygote; Male; Mice; Mice, Inbred Strains; Mutation, Missense; Myosin Heavy Chains; Phenotype; Refractory Period, Electrophysiological; Sex Factors; Sinoatrial Node; Tachycardia, Ventricular | 1998 |
Identification of an Arg403Gln beta myosin heavy chain gene mutation in a Portuguese family with hypertrophic cardiomyopathy.
Topics: Amino Acid Substitution; Arginine; Cardiomyopathy, Hypertrophic; Electrophoresis, Agar Gel; Electrophoresis, Polyacrylamide Gel; Female; Glutamine; Humans; Male; Mutation; Myosin Heavy Chains; Pedigree; Polymerase Chain Reaction; Polymorphism, Single-Stranded Conformational; Portugal | 2000 |